Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Healthcare Capital (SHC) is a state-authorized healthcare investment platform established to support the development of the biomedical industry in Shanghai. Managed by Shanghai Industrial Investment Holdings (SIIC), the fund focuses on strategic investments across the life sciences spectrum, including innovative drug development, high-end medical devices, and healthcare services. The fund aims to leverage Shanghai's industrial resources to foster global innovation and facilitate mergers and acquisitions within the healthcare sector. By providing significant capital and industrial synergy, SHC accelerates the commercialization of breakthrough medical technologies and strengthens the regional healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Healthcare M&A Fund.